Webinar | January 2, 2019

CCI Testing And Revisions To EU Annex 1

The draft of the revised EU Annex 1, on manufacturing of sterile medicinal products, was recently released. At a first glance the changes might seem subtle, however the new language will likely have a significant impact on your CCI testing practices. Regulators are paying closer attention to the proper design of robust CCI studies, validation of CCI testing methods and the generation of statistical data. In this webinar we will go over CCI testing strategies and the proposed revisions to EU Annex 1.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: